Whats YA waiting for if all they want is to take the assets?
when does that first conversion take place...wonder if YA already
Unless the Investor provides sixty-five (65) days prior written notice to the Company,
& btw can't seem to find any other defaults as the time frame for the hiring of the new CFO hasn't passed currently. Are there more even
Filing Detail
SEC Home » Search the Next-Generation EDGAR System » Company Search » Current Page
Form 8-K - Current report SEC Accession No. 0001013762-14-000222 Filing Date 2014-03-12 Accepted 2014-03-11 18:44:36 Documents 8 Period of Report 2014-03-11 Filing Date Changed 2014-03-11 Items Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Document Format Files Seq Description Document Type Size 1 INTELLICELL BIOSCIENCES, INC. FORM 8-K form8k.htm 8-K 40320 2 EXHIBIT 10.1 ex101.htm EX-10.1 359223 3 EXHIBIT 10.2 ex102.htm EX-10.2 115913 4 EXHIBIT 10.3 ex103.htm EX-10.3 75039 5 EXHIBIT 10.4 ex104.htm EX-10.4 84377 6 EXHIBIT 10.5 ex105.htm EX-10.5 539597 7 EXHIBIT 10.6 ex106.htm EX-10.6 152871 8 EXHIBIT 10.7 ex107.htm EX-10.7 86434 Complete submission text file 0001013762-14-000222.txt 1455264 Mailing Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021 Business Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021 (212) 249-3050 Intellicell Biosciences, Inc. (Filer) CIK: 0001125280 (see all company filings)
IRS No.: 911966948 | State of Incorp.: NV | Fiscal Year End: 0307 Type: 8-K | Act: 34 | File No.: 000-54729 | Film No.: 14685639 SIC: 3841 Surgical & Medical Instruments & Apparatus Assistant Director 10
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.